Calidi Biotherapeutics Inc. (CLDI) — Defensive Interval Ratio

Latest as of June 2025: 3 days

Calidi Biotherapeutics Inc. (CLDI) has a Defensive Interval Ratio of 3 days as of June 2025. Defensive assets of $50.00K (cash $-, short-term investments $-, receivables $50.00K) cover 3 days of daily cash needs of $14.67K/day. See CLDI net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

3 days
Days of operational coverage

Defensive Assets

$50.00K
Cash + ST Investments + Receivables

Daily Cash Need

$14.67K
Current Liabilities ÷ 365

Current Liabilities

$5.35 Million
USD

Calidi Biotherapeutics Inc. Defensive Interval Ratio (2022–2023)

This chart shows how Calidi Biotherapeutics Inc.'s Defensive Interval Ratio has evolved across 2 annual periods from 2022 to 2023. As of June 2025, the ratio stands at 3 days, meaning defensive assets of $50.00K can fund 3 days of operations without new revenue. See Calidi Biotherapeutics Inc. (CLDI) balance sheet quality index to measure how much of total assets are equity-financed.

Annual Defensive Interval Ratio for Calidi Biotherapeutics Inc. (2022–2023)

The table below presents the year-by-year Defensive Interval Ratio for Calidi Biotherapeutics Inc. from 2022 to 2023, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market value of Calidi Biotherapeutics Inc..

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2023 49 days $1.36 Million $28.03K/day $- $- ▲ +49 days
2022 0 days $870.00 $117.78K/day $- $-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)